Bill > HB919

This bill mandates that Pharmacy Benefit Managers (PBMs), which are companies that manage prescription drug benefits on behalf of health insurers, must reimburse licensed pharmacies and pharmacists at least the National Average Drug Acquisition Cost (NADAC) plus a professional dispensing fee, adjusted for inflation, or the wholesale acquisition cost plus the dispensing fee if NADAC is unavailable, and that PBMs must cover the costs of any under-reimbursed dispensing fees without passing them on to plans, members, pharmacies, or pharmacists. Additionally, the bill requires PBMs to disclose certain financial terms and arrangements with drug manufacturers and labels to covered entities, and it clarifies that PBMs owe a fiduciary duty, meaning they must act in good faith and with honesty and candor, to beneficiaries and contracting entities, with failure to do so being a violation of the Unfair Trade Practices and Consumer Protection Law. The bill also requires PBMs to list any foreign subsidiaries in their annual transparency reports and makes the provisions regarding reimbursement retroactive to January 1, 2026.

Business and Industry, Health and Social Services

https://www.legis.la.gov/legis/BillInfo.aspx?s=26rs&b=HB919&sbi=y